{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T19:46:36Z","timestamp":1794599196696,"version":"4.9.1"},"reference-count":170,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijgc.2025.102747","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T15:57:04Z","timestamp":1760803024000},"page":"102747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-9356","authenticated-orcid":false,"given":"David","family":"Cibula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisa","family":"Mburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Planchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9175-7767","authenticated-orcid":false,"given":"Ignacio","family":"Zapardiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1537-5254","authenticated-orcid":false,"given":"David","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-090X","authenticated-orcid":false,"given":"Sarah","family":"al-Rubaish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8193-5582","authenticated-orcid":false,"given":"Glauco","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Elghazaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-4216","authenticated-orcid":false,"given":"Fernando","family":"Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3434-1677","authenticated-orcid":false,"given":"Bothwell","family":"Guzha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kamfwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3283-5064","authenticated-orcid":false,"given":"Arb-Aroon","family":"Lertkhachonsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Mahantshetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Antonio","family":"Martinez Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-2101","authenticated-orcid":false,"given":"Olga","family":"Matylevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asima","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-0438","authenticated-orcid":false,"given":"Rene","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher","family":"Slimane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Refky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib1","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer - Update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2025.102747_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109682","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer - Update 2023","volume":"184","author":"Cibula","year":"2023","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102747_bib4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00428-023-03552-3","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer - Update 2023","volume":"482","author":"Cibula","year":"2023","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clon.2014.10.006","article-title":"Need for radiotherapy in low and middle income countries - the silent crisis continues","volume":"27","author":"Zubizarreta","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijgc.2025.102747_bib6","article-title":"Challenges faced in managing cervical cancer patients who present post-operatively with more advanced disease in LMICs: case studies from Cameroon","volume":"55","author":"Ngalla","year":"2024","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ijgc.2025.102747_bib7","article-title":"Access to brachytherapy treatment for cervical cancer management in Africa","volume":"50","author":"Fiagbedzi","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102747_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1470-2045(06)70759-8","article-title":"Role of radiotherapy in cancer control in low-income and middle-income countries","volume":"7","author":"Barton","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0167-8140(01)00330-9","article-title":"Quantitative status of resources for radiation therapy in Asia and Pacific region","volume":"60","author":"Tatsuzaki","year":"2001","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102747_bib11","first-page":"349","article-title":"Radiation therapy services in South Africa","volume":"84","author":"Levin","year":"1994","journal-title":"S Afr Med J"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0167-8140(99)00069-9","article-title":"Radiation therapy in Africa: distribution and equipment","volume":"52","author":"Levin","year":"1999","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.radonc.2004.07.022","article-title":"Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA)","volume":"73","author":"Zubizarreta","year":"2004","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib14","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/S1470-2045(12)70532-6","article-title":"Status of radiotherapy resources in Africa: an International Atomic Energy Agency analysis","volume":"14","author":"Abdel-Wahab","year":"2013","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib15","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/S1470-2045(12)70556-9","article-title":"Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database","volume":"14","author":"Rosenblatt","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijrobp.2014.03.002","article-title":"Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020","volume":"89","author":"Datta","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0167-8140(02)00010-5","article-title":"Radiotherapy services in countries in transition: gross national income per capita as a significant factor","volume":"63","author":"Levin","year":"2002","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.ijgc.2025.102747_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(04)01613-4","article-title":"Improvement of radiotherapy facilities in developing countries: a three-tier system with a teleradiotherapy network","volume":"5","author":"Datta","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib19","article-title":"Training the trainees in radiation oncology with telemedicine as a tool in a developing country: a two-year audit","volume":"2011","author":"Agrawal","year":"2011","journal-title":"Int J Telemed Appl"},{"issue":"9747","key":"10.1016\/j.ijgc.2025.102747_bib20","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0140-6736(10)61152-X","article-title":"Expansion of cancer care and control in countries of low and middle income: a call to action","volume":"376","author":"Farmer","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ijgc.2025.102747_bib21","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.1634\/theoncologist.2019-0057","article-title":"Delays and barriers to cancer care in low- and middle-income countries: A systematic review","volume":"24","author":"Brand","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.ijgc.2025.102747_bib22","article-title":"Modern radiotherapy technology: obstacles and opportunities to access in low- and middle-income countries","volume":"8","author":"Maitre","year":"2022","journal-title":"JCO Glob Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102747_bib23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gore.2017.08.004","article-title":"Cervical cancer in low and middle income countries: addressing barriers to radiotherapy delivery","volume":"22","author":"LaVigne","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.ijgc.2025.102747_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.gore.2017.01.003","article-title":"Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): common efforts and challenges","volume":"20","author":"Johnston","year":"2017","journal-title":"Gynecol Oncol Rep"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102747_bib26","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/S1470-2045(21)00351-X","article-title":"Radiotherapy resources in Africa: an International Atomic Energy Agency update and analysis of projected needs","volume":"22","author":"Elmore","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/sd.2639","article-title":"Building a sustainable future: closing the gap in radiotherapy and brachytherapy resources to achieve the sustainable development agenda 2030 goals for cervical cancer control in Africa","volume":"32","author":"Drokow","year":"2024","journal-title":"Sustain Dev"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.2015.62.8412","article-title":"Establishing and delivering quality radiation therapy in resource-constrained settings: the story of Botswana","volume":"34","author":"Efstathiou","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clon.2016.12.004","article-title":"Global access to radiotherapy in low- and middle-income countries","volume":"29","author":"Abdel-Wahab","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2015.06.012","article-title":"Optimal radiotherapy utilisation rate in developing countries: an IAEA study","volume":"116","author":"Rosenblatt","year":"2015","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clon.2016.11.003","article-title":"The benefits of providing external beam radiotherapy in low- and middle-income countries","volume":"29","author":"Yap","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.clon.2016.11.011","article-title":"Analysis of global radiotherapy needs and costs by geographic region and income level","volume":"29","author":"Zubizarreta","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijgc.2025.102747_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2019.06.026","article-title":"Is economic status the main determinant of radiation therapy availability? The Arab world as an example of developing countries","volume":"140","author":"Mousa","year":"2019","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7150\/ijms.17288","article-title":"Radiation therapy and cancer control in developing countries: can we save more lives?","volume":"14","author":"Baskar","year":"2017","journal-title":"Int J Med Sci"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semradonc.2016.11.011","article-title":"Challenges and prospects for providing radiation oncology services in Africa","volume":"27","author":"Balogun","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib36","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ijrobp.2017.10.047","article-title":"Radiation oncology in Egypt: A model for Africa","volume":"100","author":"Zaghloul","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"7","key":"10.1016\/j.ijgc.2025.102747_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/tmj.2014.0154","article-title":"Teleradiotherapy network: Applications and feasibility for providing cost-effective comprehensive radiotherapy care in low- and middle-income group countries for cancer patients","volume":"21","author":"Datta","year":"2015","journal-title":"Telemed J Health"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2018.06.046","article-title":"Radiation therapy availability in Africa and Latin America: two models of low and middle income countries","volume":"102","author":"Bishr","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijgc.2025.102747_bib39","first-page":"1","article-title":"External radiation and brachytherapy resource deficit for cervical cancer in India: call to action for treatment of all","volume":"5","author":"Chopra","year":"2019","journal-title":"J Glob Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/ijc.IJC_82_19","article-title":"Radiotherapy in India: history, current scenario and proposed solutions","volume":"56","author":"Munshi","year":"2019","journal-title":"Indian J Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijrobp.2013.12.008","article-title":"Implementation of a high-dose-rate brachytherapy program for carcinoma of the cervix in Senegal: a pragmatic model for the developing world","volume":"89","author":"Einck","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib42","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ijrobp.2016.04.026","article-title":"The stagnation and decay of radiation oncology resources: lessons from Nigeria","volume":"95","author":"Irabor","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brachy.2016.10.007","article-title":"American Brachytherapy Society: brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries","volume":"16","author":"Suneja","year":"2017","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.canrad.2016.01.010","article-title":"Implementing radiotherapy in Africa: focus on the needs in Rwanda","volume":"20","author":"Kamanzi","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijgc.2025.102747_bib45","first-page":"380","article-title":"A systematic review of radiotherapy capacity in low- and middle-income countries","volume":"4","author":"Grover","year":"2014","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.semradonc.2016.11.005","article-title":"The unique issues with brachytherapy in low- and middle-income countries","volume":"27","author":"Grover","year":"2017","journal-title":"Semin Radiat Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102747_bib47","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1634\/theoncologist.2013-0393","article-title":"Cervical brachytherapy exchange: steps toward oncology capacity building in Botswana","volume":"19","author":"Bvochara-Nsingo","year":"2014","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ijrobp.2013.12.032","article-title":"Radiation oncology in Africa: improving access to cancer care on the African continent","volume":"89","author":"Fisher","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102747_bib49","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa2308900","article-title":"Simple versus radical hysterectomy in Women with Low-Risk Cervical Cancer","volume":"390","author":"Plante","year":"2024","journal-title":"N Engl J Med."},{"issue":"10434","key":"10.1016\/j.ijgc.2025.102747_bib50","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"10460","key":"10.1016\/j.ijgc.2025.102747_bib51","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(24)01808-7","volume":"404","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"American Society of Blood and Marrow Transplantation\u2019Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib53","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinids\/18.3.421","article-title":"Purpose of quality standards for infectious diseases. Infectious Diseases Society of America","volume":"18","author":"Gross","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/ijgc-2021-002422","article-title":"The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries","volume":"31","author":"McCormack","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib55","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ygyno.2012.09.025","article-title":"Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial","volume":"128","author":"Epstein","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib56","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1136\/ijgc-2023-ESGO.4","article-title":"#451 Magnetic resonance imaging or expert ultrasound in preoperative local staging of patients with early-stage cervical cancer: final results of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-CX2)","volume":"33","author":"Koci\u00e1n","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2006-933605","article-title":"European Federation of Societies for Ultrasound in Medicine Biology. Minimum training recommendations for the practice of medical ultrasound","volume":"27","year":"2006","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.ijgc.2025.102747_bib58","article-title":"Ultrasound assessment of the pelvic sidewall: methodological consensus opinion","author":"Fischerova","year":"2024","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ijgc.2025.102747_bib59","article-title":"Ultrasound assessment of lymph nodes for staging of gynecological cancer: consensus opinion on terminology and examination technique","author":"Fischerova","year":"2024","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102747_bib60","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/uog.23617","article-title":"Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group","volume":"57","author":"Fischerova","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/uog.10054","article-title":"Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review","volume":"38","author":"Fischerova","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/ijgc-2023-004609","article-title":"Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statements","volume":"34","author":"Fischerova","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16040775","article-title":"The role of imaging in cervical cancer staging: ESGO\/ESTRO\/ESP guidelines (Update 2023)","volume":"16","author":"Fischerova","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102747_bib66","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/ijgc-2024-005341","article-title":"Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer","volume":"34","author":"Fruhauf","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib67","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/S1470-2045(12)70011-6","article-title":"Nodal-staging surgery for locally advanced cervical cancer in the era of PET","volume":"13","author":"Gouy","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2016.11.011","article-title":"Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer","volume":"144","author":"Shim","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2019.02.007","article-title":"Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort","volume":"134","author":"Nomden","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib70","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"Potter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib71","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2011.11.037","article-title":"Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer","volume":"124","author":"Cibula","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.ijgc.2025.102747_bib72","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1200\/JCO.2010.32.0432","article-title":"Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study","volume":"29","author":"Lecuru","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2011.04.023","article-title":"Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer","volume":"122","author":"Cormier","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2017.02.005","article-title":"Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer","volume":"145","author":"Salvo","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2024.06.015","article-title":"Sentinel lymph node pathological ultrastaging: final outcome of the Sentix prospective international study in patients with early-stage cervical cancer","volume":"188","author":"Kocian","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-025-01016-y","article-title":"Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, non-inferiority, international trial","author":"Cibula","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ijgc.2025.102747_bib77","series-title":"SGO Annual Meeting","article-title":"Sentinel Lymph Node Biopsy versus Pelvic Lymphadenectomy in Cervical Cancer: the PHENIX-I trial","author":"Liu","year":"2025"},{"key":"10.1016\/j.ijgc.2025.102747_bib78","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejca.2021.02.009","article-title":"Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: Results of a multicentre randomised trial (SENTICOL-2)","volume":"148","author":"Mathevet","year":"2021","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102747_bib79","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/ijgc-2023-004692","article-title":"Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review","volume":"33","author":"Mauro","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2025.102747_bib80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2020.06.034","article-title":"Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial","volume":"137","author":"Cibula","year":"2020","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2009.09.003","article-title":"Pelvic lymphadenectomy in cervical cancer--surgical anatomy and proposal for a new classification system","volume":"116","author":"Cibula","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.2000.6010","article-title":"Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study","volume":"80","author":"Landoni","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib83","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/IGC.0000000000001228","article-title":"Surgical Treatment of Early-Stage Cervical Cancer: A Multi-Institution Experience in 2124 Cases in The Netherlands Over a 30-Year Period","volume":"28","author":"Derks","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib84","doi-asserted-by":"crossref","first-page":"428 e1","DOI":"10.1016\/j.ajog.2023.06.030","article-title":"Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study","volume":"229","author":"Bizzarri","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib85","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/0090-8258(90)90072-S","article-title":"Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"38","author":"Delgado","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib86","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2021.06.017","article-title":"Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG\/GOG ancillary analysis","volume":"162","author":"Levinson","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib87","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2018.10.018","article-title":"Surgical treatment of \"intermediate risk\u201d lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature","volume":"151","author":"Cibula","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib88","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/ijgc-2019-000445","article-title":"Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy","volume":"29","author":"van der Velden","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102747_bib89","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ijgc-2021-002489","article-title":"Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors","volume":"31","author":"Nasioudis","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib90","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ygyno.2021.06.026","article-title":"Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria","volume":"162","author":"Haesen","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib91","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2023.01.014","article-title":"Role of adjuvant therapy in intermediate-risk cervical cancer patients - Subanalyses of the SCCAN study","volume":"170","author":"Cibula","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"18","key":"10.1016\/j.ijgc.2025.102747_bib92","doi-asserted-by":"crossref","first-page":"18557","DOI":"10.1002\/cam4.6460","article-title":"Heterogeneous treatment effects of adjuvant therapy for patients with cervical cancer in the intermediate-risk group","volume":"12","author":"Taguchi","year":"2023","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102747_bib93","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/ijgc-2024-005597","article-title":"Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer","volume":"34","author":"Matsuo","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ijgc.2025.102747_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17081320","article-title":"Adjuvant Therapy in \"Intermediate-Risk\u201d Early-Stage Cervical Cancer: To Treat or Not to Treat? Systematic Review and Meta-Analysis","volume":"17","author":"Ripepi","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijgc.2025.102747_bib95","article-title":"Adjuvant Chemotherapy versus Concurrent Chemoradiotherapy for Surgically Treated T1b Uterine Cervical Cancer: A Propensity Score Matched Analysis of the JSOG Nationwide Data","author":"Tanaka","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib96","article-title":"Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer","author":"Nishimura","year":"2024","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib97","article-title":"Efficacy and safety of consolidation chemotherapy after adjuvant therapy in stage IB-IIA cervical cancer patients with risk factors: a retrospective single-center study","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"issue":"9077","key":"10.1016\/j.ijgc.2025.102747_bib98","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet."},{"issue":"12","key":"10.1016\/j.ijgc.2025.102747_bib99","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1159\/000508569","article-title":"Is Adjuvant Therapy Necessary for Patients with Intermediate-Risk Cervical Cancer after Open Radical Hysterectomy?","volume":"98","author":"Yahata","year":"2020","journal-title":"Oncology"},{"issue":"16","key":"10.1016\/j.ijgc.2025.102747_bib100","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102747_bib101","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/bjc.2013.179","article-title":"Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)","volume":"108","author":"Katsumata","year":"2013","journal-title":"Br J Cancer"},{"issue":"32","key":"10.1016\/j.ijgc.2025.102747_bib102","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1200\/JCO.22.02852","article-title":"Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994","volume":"41","author":"Kenter","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib103","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1186\/s12885-022-10355-3","article-title":"Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial","volume":"22","author":"Hu","year":"2022","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266001","article-title":"Clinical outcome of FIGO 2018 stage IB3\/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy","volume":"17","author":"Zeng","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijgc.2025.102747_bib105","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.940545","article-title":"Efficacy Analysis of Neoadjuvant versus Adjuvant Cisplatin-Paclitaxel Regimens for Initial Treatment of FIGO Stages IB3 and IIA2 Cervical Cancer","volume":"29","author":"Tao","year":"2023","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ijgc-2023-004928","article-title":"Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review","volume":"34","author":"Caruso","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijgc.2025.102747_bib107","article-title":"Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer-A Propensity Score Matching Analysis","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib108","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ygyno.2008.05.026","article-title":"Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study","volume":"110","author":"Chen","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.2002.20.1.179","article-title":"Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study","volume":"20","author":"Benedetti-Panici","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijgc.2025.102747_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.570258","article-title":"The Effect of Neoadjuvant Chemotherapy on Lymph Node Metastasis of FIGO Stage IB1-IIB Cervical Cancer: A Systematic Review and Meta-Analysis","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib111","doi-asserted-by":"crossref","first-page":"443 e1","DOI":"10.1016\/j.ajog.2022.11.1295","article-title":"Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment: The FERTIlity Sparing Surgery retrospective multicenter study","volume":"228","author":"Slama","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"10462","key":"10.1016\/j.ijgc.2025.102747_bib112","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","article-title":"Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial","volume":"404","author":"McCormack","year":"2024","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib113","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S1470-2045(23)00147-X","article-title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial","volume":"24","author":"Mileshkin","year":"2023","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib114","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"Potter","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib115","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijrobp.2014.07.017","article-title":"National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements","volume":"90","author":"Gill","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"35","key":"10.1016\/j.ijgc.2025.102747_bib116","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib117","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","article-title":"Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial","volume":"4","author":"Shrivastava","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib118","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/IGC.0000000000000663","article-title":"Neoadjuvant Chemotherapy Followed by Chemoradiation in Cervical Carcinoma: A Review","volume":"26","author":"de Azevedo","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"10.1016\/j.ijgc.2025.102747_bib119","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.21873\/anticanres.14485","article-title":"Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: Review of the Literature and Perspectives of Clinical Research","volume":"40","author":"Gadducci","year":"2020","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102747_bib120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.rpor.2018.09.005","article-title":"Neoadjuvant chemotherapy in woman with early or locally advanced cervical cancer","volume":"23","author":"de la Torre","year":"2018","journal-title":"Rep Pract Oncol Radiother"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib121","doi-asserted-by":"crossref","first-page":"235","DOI":"10.21147\/j.issn.1000-9604.2016.02.13","article-title":"Neoadjuvant chemotherapy for locally advanced cervical cancer","volume":"28","author":"Iwata","year":"2016","journal-title":"Chin J Cancer Res"},{"issue":"11 Suppl 2","key":"10.1016\/j.ijgc.2025.102747_bib122","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1111\/IGC.0b013e3181f60d73","article-title":"The role of neoadjuvant chemotherapy and surgery in cervical cancer","volume":"20","author":"Robova","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib123","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/ijgc-2021-002531","article-title":"Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future","volume":"32","author":"Miriyala","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"21","key":"10.1016\/j.ijgc.2025.102747_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215207","article-title":"Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: Retrospective Single-Center Study","volume":"15","author":"Mereu","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102747_bib125","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14737140.2015.1079777","article-title":"Neoadjuvant chemotherapy in cervical cancer: an update","volume":"15","author":"Lapresa","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12885-023-10517-x","article-title":"Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer","volume":"23","author":"Li","year":"2023","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.ijgc.2025.102747_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16142542","article-title":"Locally Advanced Cervical Cancer: Neoadjuvant Treatment versus Standard Radio-Chemotherapy-An Updated Meta-Analysis","volume":"16","author":"Ronsini","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.21873\/anticanres.14800","article-title":"Dose-dense Neoadjuvant Chemotherapy With Paclitaxel and Carboplatin in Cervical Cancer: Efficacy on Pathological Response","volume":"41","author":"Di","year":"2021","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib129","article-title":"Neoadjuvant chemotherapy for locally advanced cervix cancer","volume":"2004","author":"Tierney","year":"2004","journal-title":"Cochrane Database Syst Rev."},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000108600","article-title":"Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer","volume":"65","author":"Loizzi","year":"2008","journal-title":"Gynecol Obstet Invest"},{"issue":"11 Suppl 2","key":"10.1016\/j.ijgc.2025.102747_bib131","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1111\/IGC.0b013e3181f967ed","article-title":"Critical review of neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer","volume":"20","author":"Colombo","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib132","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3802\/jgo.2015.26.2.118","article-title":"Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma","volume":"26","author":"Scandurra","year":"2015","journal-title":"J Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib133","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/IGC.0b013e3181d80aa9","article-title":"Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results","volume":"20","author":"Mori","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102747_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310457","article-title":"Locally advanced cervical cancer: Neoadjuvant chemotherapy plus radical surgery an alternative approach to chemo-radiation in a low-income setting: A descriptive study","volume":"19","author":"Birara","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib135","first-page":"92","article-title":"The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer","volume":"21","author":"Yin","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"18","key":"10.1016\/j.ijgc.2025.102747_bib136","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2005.04.172","volume":"23","author":"Buda","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102696","article-title":"Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study","volume":"73","author":"Falconer","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib138","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3802\/jgo.2022.33.e9","article-title":"Total mesometrial resection (TMMR) for cervical cancer FIGO IB-IIA: first results from the multicentric TMMR register study","volume":"33","author":"Buderath","year":"2022","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102747_bib139","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1470-2045(09)70100-7","article-title":"Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis","volume":"10","author":"Hockel","year":"2009","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib141","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib142","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib143","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2016.03.020","article-title":"Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study","volume":"120","author":"Fokdal","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib144","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2021.05.010","article-title":"IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer","volume":"160","author":"Mahantshetty","year":"2021","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib145","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ijrobp.2018.05.080","article-title":"A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers","volume":"102","author":"Mahantshetty","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2011.08.001","article-title":"Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix","volume":"102","author":"Mahantshetty","year":"2012","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib147","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/gyno.2002.6815","article-title":"Is there a role for pelvic lymph node debulking in advanced cervical cancer?","volume":"87","author":"Kupets","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib148","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2003.12.038","article-title":"Lymph node control in cervical cancer","volume":"59","author":"Grigsby","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib149","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2014.08.013","article-title":"Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography\/computed tomography era","volume":"90","author":"Vargo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108013","article-title":"External beam radiotherapy boost versus surgical debulking followed by radiotherapy for the treatment of metastatic lymph nodes in cervical cancer: A systematic review and meta-analysis","volume":"50","author":"Bizzarri","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib151","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/jjco\/hyp191","article-title":"A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer","volume":"40","author":"Japan Clinical Oncology","year":"2010","journal-title":"Jpn J Clin Oncol."},{"issue":"3","key":"10.1016\/j.ijgc.2025.102747_bib152","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3802\/jgo.2023.34.e55","article-title":"Efficacy of lymph node dissection on stage IIICr of cervical cancer before CCRT: study protocol for a phase III, randomized controlled clinical trial (CQGOG0103)","volume":"34","author":"He","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102747_bib153","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/ijgc-2022-003357","article-title":"Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking","volume":"32","author":"Olthof","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.ijgc.2025.102747_bib154","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2241::AID-CNCR20>3.0.CO;2-T","article-title":"Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking","volume":"82","author":"Cosin","year":"1998","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ijgc.2025.102747_bib155","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0360-3016(89)90145-4","article-title":"The role of surgical debulking in cancer of the uterine cervix","volume":"17","author":"Potish","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5 Pt 1","key":"10.1016\/j.ijgc.2025.102747_bib156","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0002-9378(89)90160-9","article-title":"Pretreatment surgical staging in cervical carcinoma: therapeutic efficacy of pelvic lymph node resection","volume":"160","author":"Downey","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ijgc.2025.102747_bib157","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ijgc-2021-002921","article-title":"ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer","volume":"31","author":"Schmeler","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib159","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly","year":"2018","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/cid\/ciu174","article-title":"Management of HIV infection in patients with cancer receiving chemotherapy","volume":"59","author":"Torres","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijgc.2025.102747_bib161","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.gore.2017.07.009","article-title":"Cervical cancer control in HIV-infected women: Past, present and future","volume":"21","author":"Ghebre","year":"2017","journal-title":"Gynecol Oncol Rep"},{"issue":"31","key":"10.1016\/j.ijgc.2025.102747_bib162","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1200\/JCO.2016.67.9613","article-title":"HIV Infection and Survival Among Women With Cervical Cancer","volume":"34","author":"Dryden-Peterson","year":"2016","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijgc.2025.102747_bib163","article-title":"Impact of hydronephrosis and kidney function on survival in newly diagnosed advanced cervical cancer","volume":"39","author":"Damian","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"10.1016\/j.ijgc.2025.102747_bib164","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75937-6","article-title":"Hematological changes in women with cervical cancer before and after cancer treatment: retrospective cohort study","volume":"14","author":"Berta","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijgc.2025.102747_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104519","article-title":"Current management of cervical cancer in women living with HIV","volume":"204","author":"Beas-Lozano","year":"2024","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1016\/j.ijgc.2025.102747_bib166","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-6405-4-9","article-title":"Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options","volume":"4","author":"Murdoch","year":"2007","journal-title":"AIDS Res Ther"},{"issue":"6","key":"10.1016\/j.ijgc.2025.102747_bib167","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","volume":"100","author":"Classen","year":"2021","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib168","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/cncr.24878","article-title":"Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?","volume":"116","author":"Housri","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ijgc.2025.102747_bib169","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/QAI.0000000000002420","article-title":"Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV","volume":"85","author":"Grover","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.ijgc.2025.102747_bib170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12968\/jowc.2016.25.4.210","article-title":"Incidence of surgical site infection in postoperative patients at a tertiary care centre in India","volume":"25","author":"Akhter","year":"2016","journal-title":"J Wound Care"},{"key":"10.1016\/j.ijgc.2025.102747_bib171","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/GO.21.00081","article-title":"Cervical Cancer Treatment in HIV-Positive Patients: A Survey of Treatment Practices in India","volume":"7","author":"Mohanty","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.ijgc.2025.102747_bib172","article-title":"Cancer treatment and survival among cervical cancer patients living with or without HIV in South Africa","volume":"43","author":"Turdo","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"7","key":"10.1016\/j.ijgc.2025.102747_bib173","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.2024.24543","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel","volume":"333","author":"Gandhi","year":"2025","journal-title":"JAMA"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25018675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25018675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:37:40Z","timestamp":1787949460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25018675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1048891X25018675"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102747","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"European Society of Gynaecological Oncology resource-stratified guidelines for the management of patients with cervical cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2025.102747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102747"}}